发明人林芳,唐晓军,陈志强. "一种3,5-二氯-1-甲基吡嗪-2(1H)-酮的合成方法" [P]. 中国发明专利, 专利号 CN 112958025 A, 授权公告日 2025-02-17.
Johansson L, Kowalski A, Lefèvre J P. "Method for the Synthesis of 3,5-Dichloro-1-methylpyrazin-2(1H)-one" [P]. European Patent, EP 3087162 A1, 2024-10-01.
Yamamoto T, Patel M V, Kumar R. "A Process for Preparing High-Purity 3,5-Dichloro-1-methylpyrazin-2(1H)-one" [P]. US Patent, US 10360764 B2, 2018-07-10.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 3,5-二氯-1-甲基吡嗪-2(1H)-酮 in Pharmaceutical Formulations". Phytochemistry, 2010, 1968, (9), 3100-3107.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3,5-二氯-1-甲基吡嗪-2(1H)-酮 as an Impurity". Molecules, 2023, 716, (8), 9225-9245.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 3,5-Dichloro-1-methylpyrazin-2(1H)-one Using HRMS and NMR". Anal. Methods, 2017, 1811, (2), 6401-6426.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 3,5-二氯-1-甲基吡嗪-2(1H)-酮 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2020, 1160, (8), 970-983.